![]() |
||||
|
||||
|
|
||||
Neonatal Homocystinuria ScreeninFrom: Terrence.Jones@ncal.kaiperm.orgFri Apr 5 20:24:39 1996
Bert, wish there was more time to put my thoughts together, but gotta' run. The topic of trans-sulfuration defects was discussed, peripherally, by Allan Fisher, a MedGen Fellow at Emory: In January (1/23/96) it was recurrent SAB, and February (2/15/96) it was ASCVD, embolic CVA and hormonal therapy. In each case it was pertaining to HHCY (hyperhomocysteinemia). Perhaps co-factor responsiveness is dependent on the mutation site of the CBS gene (see Sebastio Am J Hum Gen 6/95, 56: 1324-33). The animal model developed by Watanabe (Proc Nat'l Acad Sci USA 2/95, 92: 1585-9) may shed some light on intervention algorithms (tho for now they seem most interested in studying heterozygotes and ASCVD risk). Since this gene shows up later (VanAerts J Rep Fertil 3/95, 103: 227-32) than the other two (MS and SAH hydrolase) it's probably not the contributing factor in NTD's, which is the assoc I've found interesting, assoc with HHCY (see Steegers-Theunissen AJOG 5/95 172:1436, and Mills Lancet 1/95 345:149). Also, regarding transmethylation (homocysteine -- methionine), as a side topic, I'd be very interested to hear your thoughts on aminopterin syndrome. What connections between folate antagonism might result in the spectrum of unusual cranio-facial defects, coupled with the anomalies in the extremities? Interesting topic, Terry.
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:18:04 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.